description
Physiogenex is a leading preclinical contrat research organization (CRO) specializing in metabolic disorders such as diabetes, obesity, liver diseases, dyslipidemia, atherosclerosis and diabetic nephropathy. Our combination of diet-induced animal models and state-of-the-art preclinical platform (in vivo, ex vivo and in vitro assays) makes Physiogenex your preferred research provider for first level phenotyping, screening and predictive proof of efficacy services in metabolic diseases and complications.